Imricor Medical Systems Inc (IMR) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.853x

Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has a cash flow conversion efficiency ratio of -0.853x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.84 Million ≈ $-6.96 Million USD) by net assets (AU$11.53 Million ≈ $8.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Imricor Medical Systems Inc fund operations to measure how many days the company can operate on defensive assets alone.

Imricor Medical Systems Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Imricor Medical Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Imricor Medical Systems Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imricor Medical Systems Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
USI Corp TW:1304	0.000x
PCL Technologies Inc TW:4977	0.004x
Vastned Retail Belgium BR:VASTB	0.014x
Beihai Gofar Marine Biological Industry Co Ltd SHG:600538	-0.015x
Calfrac Well Services Ltd. TO:CFW	0.114x
PowerFleet, Inc. NASDAQ:AIOT	0.021x
Nuveen Multi-Asset Income Fund NYSE:NMAI	-0.038x
Thaitheparos Public Company Limited BK:SAUCE	0.029x

Annual Cash Flow Conversion Efficiency for Imricor Medical Systems Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Imricor Medical Systems Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see IMR stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$11.53 Million ≈ $8.16 Million	AU$-19.75 Million ≈ $-13.97 Million	-1.712x	-181.12%
2024-12-31	AU$-7.38 Million ≈ $-5.22 Million	AU$-15.57 Million ≈ $-11.02 Million	2.111x	+42.40%
2023-12-31	AU$-8.75 Million ≈ $-6.19 Million	AU$-12.98 Million ≈ $-9.18 Million	1.483x	+167.44%
2022-12-31	AU$7.51 Million ≈ $5.31 Million	AU$-16.51 Million ≈ $-11.68 Million	-2.198x	-181.58%
2021-12-31	AU$22.40 Million ≈ $15.85 Million	AU$-17.49 Million ≈ $-12.37 Million	-0.781x	-83.94%
2020-12-31	AU$28.82 Million ≈ $20.39 Million	AU$-12.23 Million ≈ $-8.65 Million	-0.424x	+54.96%
2019-12-31	AU$7.03 Million ≈ $4.98 Million	AU$-6.63 Million ≈ $-4.69 Million	-0.942x	-100.20%
2018-12-31	AU$13.47 Million ≈ $9.53 Million	AU$-6.34 Million ≈ $-4.49 Million	-0.471x	-143.77%
2017-12-31	AU$-5.25 Million ≈ $-3.72 Million	AU$-5.65 Million ≈ $-4.00 Million	1.075x	+6.98%
2016-12-31	AU$-4.03 Million ≈ $-2.85 Million	AU$-4.05 Million ≈ $-2.87 Million	1.005x	--

About Imricor Medical Systems Inc

AU:IMR Australia Medical Devices

Market Cap

$457.57 Million

AU$646.68 Million AUD

Market Cap Rank

#12870 Global

#337 in Australia

Share Price

AU$1.83

Change (1 day)

-2.14%

52-Week Range

AU$1.20 - AU$2.20

All Time High

AU$2.79